Glycoengineering design options for IgG1 in CHO cells using precise gene editing

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Glycobiology

• Publication date

  2018-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1093/glycob/cwy022PMID 29596681
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genome editing using FACS enrichment of nuclease-expressing cells and indel detection by amplicon analysis

  2017cited by this paper
• Engineered Sialylation of Pathogenic Antibodies In Vivo Attenuates Autoimmune Disease.

  2017cited by this paper
• Therapeutic glycoprotein production in mammalian cells.

  2017cited by this paper
• Fc-Galactosylation of Human Immunoglobulin Gamma Isotypes Improves C1q Binding and Enhances Complement-Dependent Cytotoxicity

  2017cited by this paper
• Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities

  2017cited by this paper
• Glyco-Engineering of Human IgG-Fc to Modulate Biologic Activities.

  2016cited by this paper
• Glycoengineering of plants yields glycoproteins with polysialylation and other defined N-glycoforms

  2016cited by this paper
• Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis

  2016cited by this paper
• B-cell–independent sialylation of IgG

  2016cited by this paper
• A Functional Role for Antibodies in Tuberculosis.

  2016cited by this paper
• Engineering of complex protein sialylation in plants

  2016cited by this paper
• Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans

  2016cited by this paper
• Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity

  2015cited by this paper
• A common glycan structure on immunoglobulin G for enhancement of effector functions

  2015cited by this paper
• In Vitro Glycoengineering of IgG1 and Its Effect on Fc Receptor Binding and ADCC Activity

  2015cited by this paper
• Engineering yeast for producing human glycoproteins: where are we now?

  2015cited by this paper
• Fast and sensitive detection of indels induced by precise gene targeting

  2015cited by this paper
• Secretome Analysis Identifies Novel Signal Peptide Peptidase-Like 3 (SPPL3) Substrates and Reveals a Role of SPPL3 in Multiple Golgi Glycosylation Pathways*

  2015cited by this paper
• Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression

  2015cited by this paper
• Skewed Fc glycosylation profiles of anti-proteinase 3 immunoglobulin G1 autoantibodies from granulomatosis with polyangiitis patients show low levels of bisection, galactosylation, and sialylation.

  2015cited by this paper
• Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity.

  2015cited by this paper
• Rapid Preparation of Released N-Glycans for HILIC Analysis Using a Labeling Reagent that Facilitates Sensitive Fluorescence and ESI-MS Detection.

  2015cited by this paper
• Engineered CHO cells for production of diverse, homogeneous glycoproteins

  2015cited by this paper
• Production of α2,6-sialylated IgG1 in CHO cells

  2015cited by this paper
• GlycoDelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins

  2014cited by this paper
• Shedding of glycan‐modifying enzymes by signal peptide peptidase‐like 3 (SPPL3) regulates cellular N‐glycosylation

  2014cited by this paper
• High-efficiency genome editing via 2A-coupled co-expression of fluorescent proteins and zinc finger nucleases or CRISPR/Cas9 nickase pairs

  2014cited by this paper
• Precision genome editing: a small revolution for glycobiology.

  2014cited by this paper
• Biopharmaceutical benchmarks 2014

  2014cited by this paper
• Rapid magnetic bead based sample preparation for automated and high throughput N-glycan analysis of therapeutic antibodies.

  2014cited by this paper
• Engineering Chinese hamster ovary (CHO) cells for producing recombinant proteins with simple glycoforms by zinc-finger nuclease (ZFN)-mediated gene knockout of mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (Mgat1).

  2013cited by this paper
• Gene silencing in plants: a diversity of pathways.

  2013cited by this paper
• Engineering a human-like glycosylation to produce therapeutic glycoproteins based on 6-linked sialylation in CHO cells.

  2013cited by this paper
• Obligate Ligation-Gated Recombination (ObLiGaRe): Custom-designed nuclease-mediated targeted integration through nonhomologous end joining

  2013cited by this paper
• Tolerance induction with T cell-dependent protein antigens induces regulatory sialylated IgGs.

  2012cited by this paper
• Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions.

  2012cited by this paper
• NMR Analysis Demonstrates Immunoglobulin G N-glycans are Accessible and Dynamic

  2011cited by this paper
• In Planta Protein Sialylation through Overexpression of the Respective Mammalian Pathway

  2010cited by this paper
• Glycomics Profiling of Chinese Hamster Ovary Cell Glycosylation Mutants Reveals N-Glycans of a Novel Size and Complexity*

  2009cited by this paper
• Expression systems for therapeutic glycoprotein production.

  2009cited by this paper
• Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc

  2008cited by this paper
• Insulators: exploiting transcriptional and epigenetic mechanisms

  2006cited by this paper
• Humanization of Yeast to Produce Complex Terminally Sialylated Glycoproteins

  2006cited by this paper
• Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

  2006cited by this paper
• Establishment of FUT8 knockout Chinese hamster ovary cells: An ideal host cell line for producing completely defucosylated antibodies with enhanced antibody‐dependent cellular cytotoxicity

  2004cited by this paper
• Characterization of alpha 2,6-sialyltransferase cleavage by Alzheimer's beta -secretase (BACE1).

  2003cited by this paper
• Glycosylation Restores Survival of Chilled Blood Platelets

  2003cited by this paper
• The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity*

  2003cited by this paper
• Characterization of α2,6-Sialyltransferase Cleavage by Alzheimer's β-Secretase (BACE1)*

  2003cited by this paper
• Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity*

  2002cited by this paper
• Engineering the protein N-glycosylation pathway in insect cells for production of biantennary, complex N-glycans.

  2002cited by this paper
• Essentials of Glycobiology

  1999cited by this paper
• Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity

  1999cited by this paper
• Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins

  1999cited by this paper
• The alpha1-6-fucosyltransferase gene and its biological significance.

  1999cited by this paper
• The α1-6-fucosyltransferase gene and its biological significance

  1999cited by this paper
• The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H.

  1995cited by this paper
• Crystal structure of the complex of rat neonatal Fc receptor with Fc

  1994cited by this paper
• Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region.

  1989cited by this paper
• Survival of recombinant erythropoietin in the circulation: the role of carbohydrates.

  1989cited by this paper
• Alteration of terminal glycosylation sequences on N-linked oligosaccharides of Chinese hamster ovary cells by expression of beta-galactoside alpha 2,6-sialyltransferase.

  1989cited by this paper
• Supplement To: the Genomic Sequence of the Chinese Hamster Ovary (cho)-k1 Cell Line

  year unknowncited by this paper

• Decoding Protein Glycosylation for Better Vaccine and Antibody Development.

  2026cites this paper
• Making Universal Vaccines and Antibodies Through Glycoengineering.

  2025cites this paper
• Cell-based glycoengineering for production of homogeneous and specific glycoform-enriched antibodies with improved effector functions

  2025cites this paper
• Recent advances in antibody glycoengineering for the gain of functions.

  2024cites this paper
• Mammalian cell-based production of glycans, glycopeptides and glycomodules

  2024cites this paper
• Modifying the Glycocalyx of Melanoma Cells via Metabolic Glycoengineering Using N-Acetyl-d-glucosamine Analogues

  2024cites this paper
• Enhancing pharmacokinetic and pharmacodynamic properties of recombinant therapeutic proteins by manipulation of sialic acid content.

  2023cites this paper
• Combinatory glycoengineering of monoclonal antibodies and its application in cancer therapy: a narrative review

  2023cites this paper
• Cell-based production of Fc-GlcNAc and Fc-alpha-2,6 sialyl glycan enriched antibody with improved effector functions through glycosylation pathway engineering

  2023cites this paper
• Modulating antibody effector functions by Fc glycoengineering.

  2023cites this paper
• CRISPR Technologies in Chinese Hamster Ovary Cell Line Engineering

  2023cites this paper
• CRISPR‐interceded CHO cell line development approaches

  2023cites this paper
• Role of N-Glycosylation in FcγRIIIa interaction with IgG

  2022cites this paper
• SARS-CoV-2 spike protein variant binding affinity to an angiotensin-converting enzyme 2 fusion glycoproteins

  2022cites this paper
• Sialylation as an Important Regulator of Antibody Function

  2022cites this paper
• Enhancing the yield and activity of defucosylated antibody produced by CHO-K1 cells using Cas13d-mediated multiplex gene targeting

  2021cites this paper
• Genetic glycoengineering in mammalian cells

  2021cites this paper
• Glycoengineering Chinese hamster ovary cells: a short history

  2021cites this paper
• Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases

  2021cites this paper
• Multiplexed engineering glycosyltransferase genes in CHO cells via targeted integration for producing antibodies with diverse complex-type N-glycans

  2021cites this paper
• FUT8-Directed Core Fucosylation of N-glycans Is Regulated by the Glycan Structure and Protein Environment

  2021cites this paper
• Monoclonal Antibody Glycoengineering for Biopharmaceutical Quality Assurance

  2021cites this paper
• An Omic’s Data-Driven Approach Towards Engineering Mammalian Cell Factories and Bioprocesses for Biopharmaceutical Production

  2021cites this paper
• Engineering Mammalian Cells to Produce Plant-Specific N-glycosylation on Proteins.

  2020cites this paper
• Meta-heterogeneity: Evaluating and Describing the Diversity in Glycosylation Between Sites on the Same Glycoprotein

  2020cites this paper
• NMR of glycoproteins: profiling, structure, conformation and interactions.

  2020cites this paper
• Global view of human protein glycosylation pathways and functions

  2020cites this paper
• Meta-heterogeneity: evaluating and describing the diversity in glycosylation between sites on the same glycoprotein.

  2020cites this paper
• Cell-Free Synthetic Glycobiology: Designing and Engineering Glycomolecules Outside of Living Cells

  2020cites this paper
• Resource An Atlas of Human Glycos ylation Pathways Enables Display of the Human Glycome by Gene Engineered Cells Graphical Abstract Highlights

  2019cites this paper
• A validated collection of mouse monoclonal antibodies to human glycosyltransferases functioning in mucin-type O-Glycosylation.

  2019cites this paper
• Small-molecule control of antibody N-glycosylation in engineered mammalian cells

  2019cites this paper
• On enzymatic remodeling of IgG glycosylation; unique tools with broad applications

  2019cites this paper
• An Atlas of Human Glycosylation Pathways Enables Display of the Human Glycome by Gene Engineered Cells.

  2019cites this paper
• IDENTIFYING FUNCTIONAL COMPONENTS OF THE ENDOPLASMIC RETICULUM QUALITY CONTROL AND DEGRADATION FACTOR EDEM1

  2018cites this paper
• EDEM 1 redox sensitive binding and catalytic activity 1 EDEM 1 ’ s mannosidase-like domain binds ERAD client proteins in a redox-sensitive manner and possesses catalytic activity

  2018cites this paper
• EDEM1's mannosidase-like domain binds ERAD client proteins in a redox-sensitive manner and possesses catalytic activity

  2018cites this paper
• Direct quality control of glycoengineered erythropoietin variants

  2018cites this paper
• Targeted Analysis of Lysosomal Directed Proteins and Their Sites of Mannose-6-phosphate Modification*

  2018cites this paper